$3.51
-0.06-1.68%
At close: -
$3.40
-0.11-3.13%
After Hours: Jan 14, 4:20 PM EDT
Comments
Loading...
Scinai Immunotherapeutics (NASDAQ:SCNI) Stock, Earnings Estimates, EPS, And Revenue
Scinai Immunotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 22
EPS
$-8.400
Quarterly Revenue
$168.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$452.00K
Analyze the earnings history of Scinai Immunotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Scinai Immunotherapeutics (SCNI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2023-08-11 | $-1.20 | $-0.91 | -31.9 % |
| Q1 | 2023-05-15 | $-1.20 | $-0.73 | -64.4 % |
| Q4 | 2023-04-17 | $0 | $-0.10 | 100.0 % |
| Q3 | 2022-11-30 | $0.06 | $-0.10 | 160.0 % |
Scinai Immunotherapeutics (SCNI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?
Scinai Immunotherapeutics (SCNI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 22, 2024 for Q3.
What were the latest earnings per share (EPS) for Scinai Immunotherapeutics (NASDAQ:SCNI)?
Scinai Immunotherapeutics (SCNI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 22, 2024 for Q3 and the Actual EPS was $-8.40, which missed the estimate of $0.00.
What were Scinai Immunotherapeutics’s (NASDAQ:SCNI) revenues?
Scinai Immunotherapeutics (SCNI) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 22, 2024 for Q3 and the Actual Revenue was $168K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.